Obesity drug endorsed by NICEBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7287.637/b (Published 17 March 2001) Cite this as: BMJ 2001;322:637
- Jacqui Wise
The anti-obesity drug orlistat (Xenical) should be available throughout England and Wales on the NHS, the government's drug advisory body has recommended. The decision by the National Institute for Clinical Excellence (NICE) should put an end to “postcode prescribing,” which has led to a 16-fold difference between the areas where it is most commonly prescribed and the areas where it is least prescribed.
The institute sets outs strict guidelines for prescribing orlistat as one part of the management of obesity. It should be prescribed only to adults (aged 18 to 75 …
Log in using your username and password
Log in through your institution
Sign up for a free trial